Zemiglo
Zemiglo Uses, Dosage, Side Effects, Food Interaction and all others data.
Zemiglo is under investigation in Type 2 Diabetes Mellitus. Zemiglo has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
Trade Name | Zemiglo |
Generic | Gemigliptin |
Gemigliptin Other Names | Gemigliptin |
Weight | 50mg |
Type | Tablet |
Formula | C18H19F8N5O2 |
Weight | Average: 489.37 Monoisotopic: 489.141100176 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | Sanofi |
Available Country | India |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Zemiglo is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
Zemiglo is also used to associated treatment for these conditions: Type 2 Diabetes Mellitus
Innovators Monograph
You find simplified version here Zemiglo